ACTRN12626000866303进行中（未招募）不适用
Validation and Assessment of the English Version of the Eating Behaviours for Obesity (EBAO) Tool in a Multi-Ethnic New Zealand Population with Obesity
James Shand Te Whatu Ora Counites Manukau0 个研究点目标入组 200 人开始时间: 2026年8月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Planned to undergo treatment at the Te Mana Ki Tua specialist weight management service
- •Aged 18-65 years
- •Fluent in English
- •BMI > 30 kg/m2
排除标准
- •No access to a computer or device to complete questionnaires
- •Non-fluent in English
- •BMI < 30 kg/m2
研究者
相似试验
进行中（未招募）
不适用
Study to check the safety and efficacy of cosmetic productCTRI/2026/07/113999Bajaj Consumer Care Ltd30
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
1 期
A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D Mutation2025-521062-10-00Arvinas Operations Inc.51
已完成
1 期
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)2023-505684-36-00Janssen - Cilag International92